{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:36:17Z","timestamp":1753439777390,"version":"3.37.3"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004567","name":"Government of Bangladesh Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jvacx.2024.100493","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T02:31:57Z","timestamp":1715135517000},"page":"100493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Investigation of the vaccine potential of an in silico designed FepA peptide vaccine against Shigella flexneri in mice model"],"prefix":"10.1016","volume":"18","author":[{"given":"Md. Rayhan","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Omar","family":"Faruque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Imam","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Akhter","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M. Kaderi","family":"Kibria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2024.100493_b0005","doi-asserted-by":"crossref","DOI":"10.1080\/23311932.2015.1013771","article-title":"Detection of foodborne pathogens by qPCR: A practical approach for food industry applications","author":"Chapela","year":"2015","journal-title":"Cogent Food Agric"},{"key":"10.1016\/j.jvacx.2024.100493_b0010","article-title":"Van Der Putten WH","author":"Jeffery","year":"2011","journal-title":"Soil Borne Human Diseases"},{"key":"10.1016\/j.jvacx.2024.100493_b0015","doi-asserted-by":"crossref","DOI":"10.1201\/NOE1420053487","author":"Clontz","year":"2008","journal-title":"Microbial Limit and Bioburden Tests"},{"key":"10.1016\/j.jvacx.2024.100493_b0020","first-page":"133","article-title":"Shigellosis","volume":"43","author":"Niyogi","year":"2005","journal-title":"J Microbiol"},{"key":"10.1016\/j.jvacx.2024.100493_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/172.5.1408","article-title":"Prevalence of Shigella enterotoxin 1 among shigella clinical isolates of diverse serotypes","author":"Noriega","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100493_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.femsle.2005.08.046","article-title":"Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors","author":"Parsot","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jvacx.2024.100493_b0035","doi-asserted-by":"crossref","DOI":"10.1128\/iai.61.9.3678-3687.1993","article-title":"Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids","author":"Taylor","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2024.100493_b0040","doi-asserted-by":"crossref","DOI":"10.2165\/00128072-200305030-00002","article-title":"Treatment of infectious diarrhea in children","author":"Alam","year":"2003","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.jvacx.2024.100493_b0045","doi-asserted-by":"crossref","DOI":"10.1097\/QCO.0000000000000475","article-title":"Recent insights into Shigella: A major contributor to the global diarrhoeal disease burden","author":"Baker","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100493_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130105","article-title":"Diarrheal illness and healthcare seeking behavior among a population at high risk for diarrhea in Dhaka","author":"Chowdhury","year":"2015","journal-title":"Bangladesh PLoS One"},{"key":"10.1016\/j.jvacx.2024.100493_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142927","article-title":"Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food","author":"Pires","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvacx.2024.100493_b0060","doi-asserted-by":"crossref","DOI":"10.2471\/BLT.05.023853","article-title":"Trend and disease burden of bacillary dysentery in China (1991\u20132000)","author":"Wang","year":"2006","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jvacx.2024.100493_b0065","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268806006029","article-title":"The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal","author":"Talukder","year":"2006","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jvacx.2024.100493_b0070","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2369","article-title":"Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe","author":"Holt","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jvacx.2024.100493_b0075","article-title":"and 2015: Trends in South India","volume":"2017","author":"Anandan","year":"2014","journal-title":"GERMS"},{"key":"10.1016\/j.jvacx.2024.100493_b0080","article-title":"Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi","author":"Trung","year":"2005","journal-title":"Vietnam Antimicrob Agents Chemother"},{"key":"10.1016\/j.jvacx.2024.100493_b0085","article-title":"to 1993","volume":"1995","author":"Lima","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jvacx.2024.100493_b0090","article-title":"Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the VASE Conference","volume":"2017","author":"Walker","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100493_b0095","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00224-16","article-title":"Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella flexneri 2a administered to healthy adults: A single-blind, randomized phase i study","author":"Riddle","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jvacx.2024.100493_b0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1568026013395623","article-title":"Structural biology of bacterial iron uptake systems","volume":"1","author":"Clarke","year":"2001","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jvacx.2024.100493_b0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15039-8","article-title":"A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model","author":"Brault","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jvacx.2024.100493_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/S0165-2478(01)00327-3","article-title":"Proinflammatory response during Ebola virus infection of primate models: Possible involvement of the tumor necrosis factor receptor superfamily","author":"Hensley","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jvacx.2024.100493_b0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/2051013613500428","article-title":"An update on vaccines against Shigella","volume":"1","author":"Ashkenazi","year":"2013","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.jvacx.2024.100493_b0120","doi-asserted-by":"crossref","DOI":"10.1007\/s10989-006-9020-9","article-title":"Regioselective disulfide solid phase synthesis, chemical characterization and in vitro receptor binding activity of equine relaxin","author":"Hossain","year":"2006","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.jvacx.2024.100493_b0125","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c01594","article-title":"Engineering of a Biologically Active Insulin Dimer","author":"Liu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jvacx.2024.100493_b0130","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau8408","article-title":"Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes","author":"Si","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.jvacx.2024.100493_b0135","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.94.14.7589","article-title":"GPIIIa-(49\u201366) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIA of HIV-1-related immunologic thrombocytopenia","author":"Nardi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvacx.2024.100493_b0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-58238-6","article-title":"Preparation of single- and double-oligonucleotide antibody conjugates and their application for protein analytics","author":"Wiener","year":"2020","journal-title":"Sci Rep"},{"year":"2011","series-title":"Antibiograms and mutagenicity evaluation of hospital wastewaters from University of Benin Teaching Hospital (UBTH)","author":"Iyekhoetin","key":"10.1016\/j.jvacx.2024.100493_b0145"},{"key":"10.1016\/j.jvacx.2024.100493_b0150","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00670-20","article-title":"DNA thermo-protection facilitates whole-genome sequencing of mycobacteria direct from clinical samples","author":"George","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jvacx.2024.100493_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/412370","article-title":"A pentaplex PCR assay for the detection and differentiation of Shigella species","author":"Ojha","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jvacx.2024.100493_b0160","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2127691","article-title":"A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx)","author":"Guo","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jvacx.2024.100493_b0165","article-title":"Development, Interlaboratory Evaluations, and Application of a Simple","author":"Nahm","year":"2018","journal-title":"High-Throughput Shigella Serum Bactericidal Assay MSphere"},{"key":"10.1016\/j.jvacx.2024.100493_b0170","doi-asserted-by":"crossref","DOI":"10.1007\/BF02111868","article-title":"Identification of Shigella and enteroinvasive Escherichia coli strains by a virulence-specific, monoclonal antibody-based enzyme immunoassay","author":"Floderus","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100493_b0175","article-title":"Safety and immunogenicity evaluation of inactivated whole-virus-SARS-COV-2 as emerging vaccine development in Egypt","author":"Saleh","year":"2021","journal-title":"Antib Ther"},{"key":"10.1016\/j.jvacx.2024.100493_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.105129","article-title":"Immunoinformatic identification of the epitope-based vaccine candidates from Maltoporin, FepA and OmpW of Shigella Spp, with molecular docking confirmation","author":"Ullah","year":"2021","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.jvacx.2024.100493_b0185","article-title":"A conserved multi-epitope-based vaccine designed by targeting hemagglutinin protein of highly pathogenic avian H5 influenza viruses. 3","author":"Bin","year":"2020","journal-title":"Biotech"},{"key":"10.1016\/j.jvacx.2024.100493_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.08.034","article-title":"Development of recombinant vaccine candidate molecule against Shigella infection","author":"Chitradevi","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100493_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2004.11.044","article-title":"Policymakers\u2019 views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia","author":"DeRoeck","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100493_b0200","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.70.7.3419-3426.2002","article-title":"Identification of the Vibrio cholerae enterobactin receptors VctA and IrgA: IrgA is not required for virulence","author":"Mey","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2024.100493_b0205","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-020-00824-4","article-title":"The identification of novel immunogenic antigens as potential Shigella vaccine components","author":"de Alwis","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.jvacx.2024.100493_b0210","doi-asserted-by":"crossref","DOI":"10.1007\/s00253-022-11988-x","article-title":"A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus","author":"Kibria","year":"2022","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.jvacx.2024.100493_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035616","article-title":"High yield production process for Shigella outer membrane particles","author":"Berlanda Scorza","year":"2012","journal-title":"PLoS One"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T20:35:19Z","timestamp":1717101319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"alternative-id":["S2590136224000664"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100493","relation":{},"ISSN":["2590-1362"],"issn-type":[{"type":"print","value":"2590-1362"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the vaccine potential of an in silico designed FepA peptide vaccine against Shigella flexneri in mice model","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100493"}}